当前位置:首页 - 行情中心 - 华仁药业(300110) - 财务分析 - 现金流量表

华仁药业

(300110)

  

流通市值:31.43亿  总市值:31.45亿
流通股本:11.81亿   总股本:11.82亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金853,217,921.99563,145,691.51252,466,216.051,374,072,879.3
  收到的税费返还0-00
  收到其他与经营活动有关的现金30,042,593.124,075,266.2710,306,300.1621,194,538.41
  经营活动现金流入小计883,260,515.09587,220,957.78262,772,516.211,395,267,417.71
  购买商品、接受劳务支付的现金382,946,552.43260,620,391.36141,329,836.79487,941,266.69
  支付给职工以及为职工支付的现金213,075,913.54149,150,445.2673,991,454.5306,498,419.34
  支付的各项税费92,972,067.368,493,182.425,178,415.15119,119,178.05
  支付其他与经营活动有关的现金65,949,779.1733,882,493.748,004,589.8891,475,024.4
  经营活动现金流出小计754,944,312.44512,146,512.76248,504,296.321,005,033,888.48
  经营活动产生的现金流量净额128,316,202.6575,074,445.0214,268,219.89390,233,529.23
二、投资活动产生的现金流量:
  收回投资收到的现金---99.8
  取得投资收益收到的现金---360,505.35
  处置固定资产、无形资产和其他长期资产收回的现金净额3,000--22,000
  处置子公司及其他营业单位收到的现金净额0--1,706,659.76
  投资活动现金流入的平衡项目0--0
  投资活动现金流入小计3,000--2,089,264.91
  购建固定资产、无形资产和其他长期资产支付的现金14,060,944.29,705,041.124,873,854.0248,980,335.29
  投资活动现金流出小计14,060,944.29,705,041.124,873,854.0248,980,335.29
  投资活动产生的现金流量净额-14,057,944.2-9,705,041.12-4,873,854.02-46,891,070.38
三、筹资活动产生的现金流量:
  取得借款收到的现金707,245,552.09556,054,854.09422,874,854.09538,845,250
  收到其他与筹资活动有关的现金0--90,000,000
  筹资活动现金流入小计707,245,552.09556,054,854.09422,874,854.09628,845,250
  偿还债务支付的现金706,043,377.89524,605,197.69371,085,020885,245,497.51
  分配股利、利润或偿付利息支付的现金29,291,495.5418,317,884.389,565,834.1547,942,004.79
  其中:子公司支付给少数股东的股利、利润---5,478,895.29
  支付其他与筹资活动有关的现金0--90,455,000
  筹资活动现金流出小计735,334,873.43542,923,082.07380,650,854.151,023,642,502.3
  筹资活动产生的现金流量净额-28,089,321.3413,131,772.0242,223,999.94-394,797,252.3
四、汇率变动对现金及现金等价物的影响-4,685.67-4,129.68-1,322.484,666.74
五、现金及现金等价物净增加额86,164,251.4478,497,046.2451,617,043.33-51,450,126.71
  加:期初现金及现金等价物余额95,349,627.1195,349,627.1195,349,627.11146,799,753.82
  期末现金及现金等价物余额181,513,878.55173,846,673.35146,966,670.4495,349,627.11
补充资料:
  净利润-30,410,148.46--459,389,075.8
  资产减值准备-8,886,794.58-586,124,422.53
  固定资产和投资性房地产折旧-42,620,795.03-84,646,779.18
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-42,620,795.03-84,646,779.18
  无形资产摊销-11,035,627.2-23,350,563.04
  长期待摊费用摊销-2,403,002.19-8,222,408.05
  处置固定资产、无形资产和其他长期资产的损失-457,758.66--7,332.49
  固定资产报废损失---284,860.15
  财务费用-18,787,729.97-41,969,585.59
  投资损失--377,296.31--2,340,718.11
  递延所得税--1,651,321.2--16,796,250.09
  其中:递延所得税资产减少--128,100.56--13,803,260.09
    递延所得税负债增加--1,523,220.64--2,992,990
  存货的减少-9,787,240.8-56,255,873.85
  经营性应收项目的减少--27,926,753.15-51,629,011.19
  经营性应付项目的增加--19,516,693.73-15,812,318.25
  现金的期末余额-173,846,673.35-95,349,627.11
  减:现金的期初余额-95,349,627.11-146,799,753.82
  现金及现金等价物的净增加额-78,497,046.24--51,450,126.71
公告日期2026-10-282026-08-272026-04-242026-04-24
审计意见(境内)标准无保留意见
TOP↑